NCT02058446View on ClinicalTrials.gov

PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Essential Hypertension
Interventions
DRUG

Amlodipine/Valsartan

Amlodipine/Valsartan: 5 mg/80 mg

Trial Locations (1)

40705

Taichung Veterans General Hospital, Taichung

All Listed Sponsors
lead

TSH Biopharm Corporation Limited

INDUSTRY

NCT02058446 - PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension | Biotech Hunter | Biotech Hunter